12:00 AM
 | 
Jan 05, 2004
 |  BioCentury  |  Finance

4Q approvals

4Q approvals

Company Approval
Alkermes (ALKS)/ FDA approves Risperdal Consta to treat schizophrenia
Johnson & Johnson (JNJ)
Amgen (AMGN)/Wyeth (WYE) FDA approves a 50 mg once-weekly dose of Enbrel etanercept...

Read the full 185 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >